The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s acute ischemic stroke drugs market report forecasts the acute ischemic stroke drugs market size to grow to $15.88 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Acute Ischemic Stroke Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-drugs-global-market-report

Acute Ischemic Stroke Drugs Market Size Forecast
The global acute ischemic stroke drugs market is expected to grow from $12.43 billion in 2022 to $13.01 billion in 2023 at a compound annual growth rate (CAGR) of 4.69%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global acute ischemic stroke drugs market size is expected to reach $15.88 billion in 2027 at a CAGR of 5.11%.

North America held the largest acute ischemic stroke drugs market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Acute Ischemic Stroke Drugs Market Driver ­– Rise In The Prevalence Of Chronic Diseases
For example, according to World Health Organisation (WHO) reports shared in September 2022, chronic diseases are expected to kill 41 million people each year, accounting for 74% of all deaths globally, and 17 million people will die before the age of 70 from chronic diseases. An estimated 164 million Americans, or approximately 49% of the population, would have chronic conditions by 2025. As a result, the rising frequency of chronic diseases is propelling the acute ischemic stroke drug market forward.

Request for A Sample Of The Global Acute Ischemic Stroke Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10049&type=smp

Key Acute Ischemic Stroke Drugs Market Trend – Adopting Strategic Clinical Development
To maintain their market position, major firms in the acute ischemic stroke medicines market are focusing on clinical development. For example, Biogen Inc., a biotechnology company based in the United States, purchased the investigational medication TMS-007 for acute ischemic stroke in May 2021. TMS-007 may be a next-generation thrombolytic with greater benefits and a lower risk profile. The TMS-007 Phase 2a research also showed positive effects on blood vessel reopening and patient functional recovery, with no symptomatic cerebral bleeding.

Acute Ischemic Stroke Drugs Market Segment
1) By Type: Tablet, Capsule, Other Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Hospitals, Diagnostic Centers, Other Applications

Acute Ischemic Stroke Drugs Market Major Players and Strategies
Major players in the acute ischemic stroke drugs market are F. Hoffmann-La Roche AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo Company Limited, AstraZeneca plc, ZZ Biotech, NoNO Inc., Biogen Inc, Athersys Inc., Bayer AG, Sanofi S.A., Pfizer Inc., DiaMedica Therapeutics, Lumosa Therapeutics Co. Ltd., Janssen Pharmaceuticals, and Acticor Biotech.

The Acute Ischemic Stroke Drugs Global Market Report 2023 covers regional data on acute ischemic stroke drugs market size, acute ischemic stroke drugs market trends and drivers, opportunities, strategies, and acute ischemic stroke drugs market competitor analysis. The countries covered in the acute ischemic stroke drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Acute ischemic stroke drugs are medications used to treat a medical emergency in which blood flow to the brain is disrupted, generally owing to a blood clot. These medications seek to improve blood flow to the damaged area of the brain and reduce brain damage.

View More Reports Related To The Acute Ischemic Stroke Drugs Market –
Drugs For Erectile Dysfunction Global Market Report 2023
Acute Myeloid Leukemia Global Market Report 2023
Stroke Management Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: